Advanced search
Publication Cover
Drug and Alcohol Review Volume 22, 2003 - Issue 3
Journal homepage
9
Views
1
CrossRef citations to date
0
Altmetric
Research Article

What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?

GABRIELE BAMMER National Center for Epidemiology and Population Health, The Australian National University, Canberra, Australia
,
WIM VAN DEN BRINK Central Committee on the Treatment of Heroin Addicts (CCBH), Utrecht, the Netherlands, Amsterdam Institute forAddiction Research and Academic Medical Center University of Amsterdam, Amsterdam, the Netherlands
,
PATRICK GSCHWEND ISF Addiction Research Institute, Zurich, Switzerland
,
VINCENT HENDRIKS Central Committee on the Treatment of Heroin Addicts (CCBH), Utrecht, the Netherlands and Parnassia Addiction Research Centre (PARC), Parnassia Mental Health Institute, The Hague, the Netherlands
&
JÜRGEN REHM ISF Addiction Research Institute, Zurich, Switzerland
Pages 363-371 | Published online: 12 Jul 2009

  • Musto DF. The American Disease. Origins of Narcotic Control, 3rd edn. New York: Oxford University Press, 1999.
  • Spear B. The early years of the “British System” in practice. In: Strang J, Gossop M, eds. Heroin addiction and drug policy: the British system. Oxford: Oxford University Press, 1994:3 – 28.
  • Strang J. "The British system": past, present and future. Int Rev Psychiatry 1989;1:109 – 20.
  • Zeltner T. Vorwort [Foreword]: Projekte des Bundesamtes für Gesundheitswesen (BAG) zur ärztlich kontrollierten Abgabe von Betäubungsmitteln [Project of the Federal Office of Public Health for a medical prescription of narcotics]. In: Rihs-Middel M, Lotti H, Stamm R, Clerc J eds: Ärztliche Verschreibung von Betäubungsmitteln. Wissenschaftliche Grundlagen und praktische Erfahrungen [The medical prescription of narcotics. Scientific foundations and practical experiences]. Bern: Verlag Hans Huber, 1996.
  • Klingemann H. Drug treatment in Switzerland: harm reduction, decentralization and community response. Addiction 1996;91:723 – 36.
  • Brink W van den, Hendriks VM, Van Ree JM. Medical coprescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands. J Drug Issues 1999;29:587 – 608.
  • Langendam MW, Van Brussel GH, Coutinho RA, Van Ameijden EJ. Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. AIDS 1999;13:1711 – 16.
  • Wodak A. HIV infection and injecting drug use in Australia: responding to a crisis. J Drug Issues 1992;22:549 – 62.
  • Nationale Drug Monitor (NDM). Jaarbericht NDM 2002 [Annual report NDM 2002]. Utrecht: Bureau NDM, 2002.
  • Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blättler R, Pfeifer S. Prescription of narcotics for heroin addicts. Main results of the Swiss National Cohort Study. Basel: Karger Verlag, 1999.
  • Driessen FMHM. Methadoncliënten in Nederland [Methadone clients in the Netherlands]. Utrecht: Bureau Driessen, 1992.
  • Driessen FMHM, Völker BGM, Kregting J, Van der Lelij B. De ontwikkeling van de situatie van methadoncliënten gedurende twee jaar [The developments in the situation of methadone clients in the course of two years]. Den Haag, Utrecht: Bureau Driessen, 1999.
  • Bammer G, Douglas RM. The ACT heroin trial proposal: an overview. Med J Aust 1996;164:690 – 2.
  • Bammer G, Dobler-Mikola A, Fleming PM, Strang J, Uchtenhagen A. The heroin prescribing debate—integrating science and politics. Science 1999;284:1277 – 8.
  • Bammer G. Provision of diamorphine (heroin) by prescription for drug dependency: issues and recommendations. CNS Drugs 1999;11:253 – 62.
  • Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler- Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001;385:1417 – 20.
  • Perneger TV, Giner F, del Rio M, Mino A. Randomisedtrial of heroin maintenance programme for addicts who fail in conventional drug treatments. Br Med J 1998;317:13 – 18.
  • Central Committee on the Treatment of Heroin Addicts (CCBH). Medical co-prescription of heroin: two randomized controlled trials. Utrecht: Central Committee on the Treatment of Heroin Addicts, 2002.
  • Gschwend P, Steffen T, Christen C, Seidenberg A, Blättler R, Gutzwiller F. Prescription of narcotics for heroin addicts. Final report. Prescription and dosage of narcotics. Z¨rich: Addiction Research Institute, 1998.
  • Gschwend P, Eschmann S, Güttinger F, Rey-Riek S, Rehm J, Uchtenhagen A. Konsum von Kokain vor, in und nach der Heroin gestützten Behandlung in der Schweiz [Consumption of cocaine before, in course of and after heroinassisted treatment in Switzerland]. Suchttherapie 2002;3:8 – 12.
  • Frei A, Steffen T, Gasser M et al. Forschungsteam PROVE. Gesundheitsoekonomische Bewertung der Versuche für eine ärztliche Verschreibung von Betäubungsmitteln (PROVE) [Health economic evaluation of the Swiss trials on the prescription of narcotics]. Sozial-Präventivmedizin 1998;43:185 – 94.
  • Frei A, Greiner R-A, Mehnert A, Dinkel R. Socioeconomic evaluation of heroin maintenance treatment—final report. In: Gutzwiller F, Steffen T eds. Cost – benefit analysis of heroin maintenance treatment: Basel: Karger, 2000:37 – 130.
  • Güttinger F, Gschwend P, Schulte B, Rehm J, Uchtenhagen A. Die Lebenssituation von Drogenabhängigen in der Heroin gestützten Behandlung in der Schweiz—Eine 6- Jahres-Katamnese [The social situation of heroin addicts in heroin-assisted treatment in Switzerland—a six-year followup study]. Sucht 2002;48:370 – 8.
  • Güttinger F, Gschwend P, Schulte B, Rehm J, Uchtenhagen A. Evaluating long-term effects of heroin-assisted treatment - the results of a 6-year follow-up. Eur Addict Res 2003;9:73 – 9.
  • Gschwend P, Rehm J, Blättler R et al. Dosages in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland—Swiss national cohort study PROVE. Eur Addict Res, in press.
  • Health Council of the Netherlands: Committee on Pharmacological Interventions in Heroin Addicts. The prescription of heroin to heroin addicts, publication no. 1995/12E, 1995. The Hague: Health Council of the Netherlands.
  • Central Committee on the Treatment of Heroin Addicts (CCBH). Investigating the medical prescription of heroin. Utrecht: Central Committee on the Treatment of Heroin Addicts, 1997.
  • Uchtenhagen A, Gutzwiller F, Dobler-Mikola A, Blättler R. Program for a medical prescription of narcotics. Interim report of the research representatives. Zurich: Addiction Research Institute, 1995.
  • Delgrande M, Kuntsche EN, Schmid H. Befragung zum Gesundheitsverhalten von 12- bis 15-jährigen SchülerInnen. Deskriptive Statistik der 1998 erhobenen Gesamtschweizer Daten [Health behaviour of 12 – 15 year-old students. Descriptive statistics of the 1998 data for Switzerland]. Lausanne: Schweizerische Fachstelle für Alkoholund andere Drogenprobleme, 1999.
  • Central Committee on the Treatment of Heroin Addicts (CCBH). Investigating the medical prescription of heroin, 2nd edn rev. Utrecht: Central Committee on the Treatment of Heroin Addicts, 1999.
  • Uchtenhagen A, Gutzwiller F, Dobler-Mikola A. Versuche für eine ärztliche Verschreibung von Betäubungsmitteln. Zweiter Zwischenbericht der Forschungsbeauftragten [Program for a medical prescription of narcotics. Second interim report of the research representatives]. Zurich: Addiction Research Institute, 1996.
  • Bundesamt für Statistik [Swiss Federal Statistical Office]. Statistik des jährlichen Bevölkerungsstands [Yearly population statistics] (ESOP) 2001. Neuchatel: Bundesamt für Statistik BFS, 2001.
  • Dobler-Mikola A, Pfeifer S, Müller V, Uchtenhagen A. Methadon- und heroinunterstützte Behandlung Opiatabhängiger im Vergleich [Methadone and heroin-assisted treatment: a comparative perspective]. Forschungsbericht no. 62. Zurich: Addiction Research Institute, 1998.
  • Rehm J, Uchtenhagen A assisted by D Dombrowski. Metaanalyse schweizerischer Arbeiten zur Verwendung von Methadon als Substitutionsmittel bei der Behandlung von Opioidabhängigkeit [A meta-analysis of Swiss research on the use of methadone in substitution treatment for opioid addicts]. Zurich: Addiction Research Institute, 2001.
  • Kilias M, Rabasa J. Does heroin prescription reduce crime? Results from the evaluation of the Swiss heroin prescription projects. Stud Crime Crime Prev 1998;7:127 – 33.
  • Chesher GB. Understanding the opioid analgesics and their effects on skills performance. Alcohol Drugs Driving 1989;5:111 – 38.
  • Hendriks VM, Van den Brink W, Blanken P, Bosman I, Van Ree JM. Heroin self-administration by means of "chasing the dragon": Pharmacodynamics and bioavailability of inhaled heroin. Eur Neuropsychopharmacol 2001;11:241 – 52.
  • Wesnes KA, McEwen J, Pritchard G. The dose and time dependent profile of cognitive impairments of alcohol in young volunteers. J Clin Pharmacol 1994;34:1021.
  • Geistlich S. Schwangerschaftsverlauf und Entzugssymptome Neugeborener in der diversifizierten Opiatabgabe Bericht nr. 51 [Course of pregnancy and withdrawal symptoms in newborns in prescription of opioids]. Zürich: Institut für Suchtforschung, 1997.
  • Gutstein HB, Akil H. Opioid analgesics. In: Goodman G, Gilman A, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics, 8th edn. Englewood: McGraw-Hill, 1990:485 – 521.
  • Ostini R, Bammer G, Dance P, Goodin R. The ethics of experimental heroin maintenance. J Med Ethics 1993;19: 175 – 82.
  • Küenzi U. Nationale Methadonstatistik [Swiss national methadone statistics]. Bern: Bundesamt für Gesundheit BAG, 2001.
  • Herrmann H, Güntzel O, Simmel U, Lehmann P. Stationäre Suchttherapie Schweiz: Angebot und Finanzierung. Gesamtschweizerische Erhebung bei Therapie-Einrichtungen im Alkohol- und Drogenbereich für die Jahre 1995 – 1998 [Inpatient addiction therapy in Switzerland: supply and financial basis. A survey of treatment institutions for the years of 1995 – 1998]. Bern: Bundesamt für Gesundheit BAG, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.